Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meditor Capital Management is a London-based investment management firm specializing in the global healthcare and life sciences sectors. Founded in 1998 by Christopher Saunders, the firm is recognized for its high-conviction, research-driven approach to investing in biotechnology and pharmaceutical companies. Meditor often maintains a concentrated portfolio and has historically taken significant stakes in mid-sized healthcare entities, acting as a long-term partner or activist investor. The firm is known for its deep expertise in clinical data analysis and regulatory pathways, which informs its investment decisions. While it operates as a hedge fund rather than a drug developer, its capital allocations have significantly impacted the growth and strategic direction of various biotech firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meditor Capital Management.